Abstract:Life expectancy is increasing throughout the world and coincides with a rise in non-communicable diseases (NCDs), especially for metabolic disease that includes diabetes mellitus (DM) and neurodegenerative disorders. The debilitating effects of metabolic disorders influence the entire body and significantly affect the nervous system impacting greater than one billion people with disability in the peripheral nervous system as well as with cognitive loss, now the seventh leading cause of death worldwide. Metabolic disorders, such as DM, and neurologic disease remain a significant challenge for the treatment and care of individuals since present therapies may limit symptoms but do not halt overall disease progression. These clinical challenges to address the interplay between metabolic and neurodegenerative disorders warrant innovative strategies that can focus upon the underlying mechanisms of aging-related disorders, oxidative stress, cell senescence, and cell death. Programmed cell death pathways that involve autophagy, apoptosis, ferroptosis, and pyroptosis can play a critical role in metabolic and neurodegenerative disorders and oversee processes that include insulin resistance, β-cell function, mitochondrial integrity, reactive oxygen species release, and inflammatory cell activation. The silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae ) (SIRT1), AMP activated protein kinase (AMPK), and Wnt1 inducible signaling pathway protein 1 (WISP1) are novel targets that can oversee programmed cell death pathways tied to β-nicotinamide adenine dinucleotide (NAD + ), nicotinamide, apolipoprotein E (APOE), severe acute respiratory syndrome (SARS-CoV-2) exposure with coronavirus disease 2019 (COVID-19), and trophic factors, such as erythropoietin (EPO). The pathways of programmed cell death, SIRT1, AMPK, and WISP1 offer exciting prospects for maintaining metabolic homeostasis and nervous system function that can be compromised during aging-related disorders and lead to cognitive impairment, but these pathways have dual roles in determining the ultimate fate of cells and organ systems that warrant thoughtful insight into complex autofeedback mechanisms.

Role of the central nervous system in cell non-autonomous signaling mechanisms of aging and longevity in mammals

Temporally controlled nervous system-to-gut signaling bidirectionally regulates longevity in

Key Signaling Pathways in Aging and Potential Interventions for Healthy Aging

Mitochondrial stress signaling in longevity: A new role for mitochondrial function in aging

Roles of renin-angiotensin system and Wnt pathway in aging-related phenotypes

Signaling circuits and the apical extracellular matrix in aging: connections identified in the nematode Caenorhabditis elegans

Considering Caenorhabditis elegans Aging on a Temporal and Tissue Scale: The Case of Insulin/IGF-1 Signaling

Targeting tissue-specific metabolic signaling pathways in aging: the promise and limitations

Mitochondrial stress in GABAergic neurons non-cell autonomously regulates organismal health and aging

SIRT1 and aging related signaling pathways

Heat Shock Proteins Function as Signaling Molecules to Mediate Neuron-Glia Communication During Aging

The Role of AhR in the Hallmarks of Brain Aging: Friend and Foe

A Brain Anti-Senescence Transcriptional Program Triggered by Hypothalamic-Derived Exosomal microRNAs

Neurons in the hypothalamus counteract ageing in mice

The molecular mechanism of aging and the role in neurodegenerative diseases

Temperature-Dependent Regulation of Proteostasis and Longevity

The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk

Hypothalamic Menin regulates systemic aging and cognitive decline

Hypothalamic gene transfer of BDNF promotes healthy aging

Model Organisms: Grandeur in the Diversity of Aging Organisms

The Nutrients-Regulated Insulin/Igf-1 and Tor Pathways Play an Important Role in C. Elegans Aging